Literature DB >> 16511229

Characterization of different crystal forms of the alpha-glucosidase MalA from Sulfolobus solfataricus.

Heidi Asschenfeldt Ernst1, Martin Willemoës, Leila Lo Leggio, Gordon Leonard, Paul Blum, Sine Larsen.   

Abstract

MalA is an alpha-glucosidase from the hyperthermophilic archaeon Sulfolobus solfataricus. It belongs to glycoside hydrolase family 31, which includes several medically interesting alpha-glucosidases. MalA and its selenomethionine derivative have been overproduced in Escherichia coli and crystallized in four different crystal forms. Microseeding was essential for the formation of good-quality crystals of forms 2 and 4. For three of the crystal forms (2, 3 and 4) full data sets could be collected. The most suitable crystals for structure determination are the monoclinic form 4 crystals, belonging to space group P2(1), from which data sets extending to 2.5 A resolution have been collected. Self-rotation functions calculated for this form and for the orthorhombic (P2(1)2(1)2(1)) form 2 indicate the presence of six molecules in the asymmetric unit related by 32 symmetry.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511229      PMCID: PMC1978162          DOI: 10.1107/S1744309105035177

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  15 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  A classification of glycosyl hydrolases based on amino acid sequence similarities.

Authors:  B Henrissat
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

3.  Pentaerythritol propoxylate: a new crystallization agent and cryoprotectant induces crystal growth of 2-methylcitrate dehydratase.

Authors:  Andrew M Gulick; Alexander R Horswill; James B Thoden; Jorge C Escalante-Semerena; Ivan Rayment
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-01-24

4.  [29] Preparation of selenomethionyl proteins for phase determination.

Authors:  Sylvie Doublié
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

Review 5.  Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Authors:  Alice Y Y Cheng; I George Fantus
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

6.  Purification and characterization of a maltase from the extremely thermophilic crenarchaeote Sulfolobus solfataricus.

Authors:  M Rolfsmeier; P Blum
Journal:  J Bacteriol       Date:  1995-01       Impact factor: 3.490

7.  New families in the classification of glycosyl hydrolases based on amino acid sequence similarities.

Authors:  B Henrissat; A Bairoch
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

8.  Mechanistic and structural analysis of a family 31 alpha-glycosidase and its glycosyl-enzyme intermediate.

Authors:  Andrew L Lovering; Seung Seo Lee; Young-Wan Kim; Stephen G Withers; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2004-10-22       Impact factor: 5.157

9.  Overexpression and rapid purification of the orfE/rph gene product, RNase PH of Escherichia coli.

Authors:  K F Jensen; J T Andersen; P Poulsen
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

10.  Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin.

Authors:  G D Van Duyne; R F Standaert; P A Karplus; S L Schreiber; J Clardy
Journal:  J Mol Biol       Date:  1993-01-05       Impact factor: 5.469

View more
  1 in total

1.  Evolutionary adaptation in fucosyllactose uptake systems supports bifidobacteria-infant symbiosis.

Authors:  Mikiyasu Sakanaka; Morten Ejby Hansen; Aina Gotoh; Toshihiko Katoh; Keisuke Yoshida; Toshitaka Odamaki; Hiroyuki Yachi; Yuta Sugiyama; Shin Kurihara; Junko Hirose; Tadasu Urashima; Jin-Zhong Xiao; Motomitsu Kitaoka; Satoru Fukiya; Atsushi Yokota; Leila Lo Leggio; Maher Abou Hachem; Takane Katayama
Journal:  Sci Adv       Date:  2019-08-28       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.